deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT03452150

D-0316 First Time in Patients Ascending Dose Study

A Phase I Study of D-0316 in Patients With Advanced Non Small Cell Lung Cancer With Mutation of Epidermal Growth Factor Receptor Tyrosine Kinase

Sponsor: InventisBio Co., Ltd

Conditions Advanced Non Small Cell Lung Cancer
Interventions D-0316
Updated 14 times since 2018 Last updated: Apr 23, 2023 Started: Jan 3, 2018 Primary completion: Aug 28, 2020 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03452150, this PHASE1 trial focuses on Advanced Non Small Cell Lung Cancer and remains completed. Sponsored by InventisBio Co., Ltd, it has been updated 14 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Mar 2020 · 10 months · monthly snapshot~Mar 2020 – ~Jul 2020 · 4 months · monthly snapshot~Jul 2020 – ~Oct 2020 · 3 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Jun 2022 · 3 months · monthly snapshot~Jun 2022 – ~May 2023 · 11 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. May 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Jun 2022 — May 2023 [monthly]

    Active Not Recruiting PHASE1

  5. Mar 2022 — Jun 2022 [monthly]

    Active Not Recruiting PHASE1

▶ Show 9 earlier versions

  1. Sep 2021 — Mar 2022 [monthly]

    Active Not Recruiting PHASE1

  2. Mar 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1

  3. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE1

  4. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  5. Jul 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE1

  6. Mar 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  7. May 2019 — Mar 2020 [monthly]

    Recruiting PHASE1

  8. Jun 2018 — May 2019 [monthly]

    Recruiting PHASE1

  9. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • InventisBio Co., Ltd
Data source: InventisBio Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations